Organigram Global (OGI) vs Retension Pharmaceuticals (RTSN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Retension Pharmaceuticals is the larger company by market cap ($87.6 million vs $82.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OGI | RTSN |
|---|---|---|
| Share price | $0.583 | $10.51 |
| Market cap | $82.27M | $87.57M |
| 1-day change | -7.40% | -19.22% |
| YTD return | -65.30% | — |
| 1-year return | -60.61% | — |
| 5-year return | -93.25% | — |
| P/E ratio (TTM) | 1.36 | — |
| Forward P/E | 27.76 | — |
| EPS (TTM) | $0.43 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.24 | $18.64 |
| 52-week low | $0.583 | $9.23 |
| Distance from 52-week high | -73.97% | -43.62% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | — | +391.63% |
| Average volume | 567.77K | 144.93K |
| Shares outstanding | 141.11M | 8.33M |
| Employees | 1,139 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Organigram Global
OGI stock →Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,139 employees
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
OGI vs RTSN FAQ
Which is bigger, Organigram Global or Retension Pharmaceuticals?
Retension Pharmaceuticals (RTSN) is larger, with a market capitalization of $87.57M compared with $82.27M for Organigram Global (OGI).
Are Organigram Global and Retension Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.